UZINDUZI WA OFISI YA KONGA TEMEKE NA KIONGOZI WA MBIO ZA MWENGE 2017


Mbio za Mwenge wa Uhuru tangia mwanzo zimekuwa kichocheo kikubwa katika kuhamasisha Maendeleo, uzalendo, Umoja, Mshikamano na kudumisha Amani ndani na nje ya Taifa letu. Mwaka huu utakuwa mwaka wa 24 tangu mbio za Mwenge wa Uhuru zirejeshwe chini ya utaratibu wa usimamizi wa serikali. Lengo ni kutimiza adhma iliyowekwa na waasisi wa Taifa hili wakati wa kuanzisha Mbio za Mwenge kama kichocheo kikubwa katika kuhamasisha Maendeleo, uzalendo, Umoja, Mshikamano na kudumisha Amani ndani na nje ya Taifa letu.

Mnamo tarehe 27/5/2017, ilikuwa ni fursa ya kuzinduliwa kwa ofisi ya Konga ya Temeke, iliyopo katika kata wa Mwembeyanga. Ofisi hiyo ilizinduliwa na Kiongozi wa Mbio za Mwenge Mh. Amour Hamud Amour.














Katika Uzinduzi huo, Mwenyekiti wa Baraza la Watu Wanaoishi na VVU Tanzania Ndg. Justine Mwinuka  ambaye pia alishiriki katika uzinduzi wa ofisi  ya Konga ya Temeke , aliishukuru Hamashauri ya Wilaya ya Temeke kwa niaba ya Baraza la taifa la watu waishio na VVU kwa kutupatia Ofisi hiyo.  

Mwenyekiti wa Baraza alipongeza uongozi wa Konga ya Temeke jinsi walivyowaunganisha WAVIU wa Temeke na kuwa na mshikamano na kushirikiana katika kutatua changamoto mbalimbali zinazowakabili WAVIU.

Akitembelea banda la WAVIU kiongozi wa mbio za mwenge Mh. Amour Hamud Amour akiambatana na Mwenyekiti wa Baraza la WAVIU Tanzania Ndugu Justine Mwinuka walishuhudia kazi mbalimbali zinazofanywa na WAVIU za ujasiriamali ili kujiongezea kipato kwa kupatiwa mitaji kutoka Halmashauri, na Kupitia miradi Mbalimbali inayotolewa na wadau mbalimbali kwenye shughuli za mwitikio wa UKIMWI.Pia walipata fursa ya kuuliza maswali na kuweza kujibiwa kwa ufasaha na waliweza kuwatia moyo ili kuhakikisha wanapambana kufikia 90-90-90 ifikapo 2020

 Aidha Mwenyekiti wa Konga ya Temeke Ndugu Peter Kisima Kwa niaba ya kamati  tendaji ya Konga alitoa shukrani za dhati kwa Halmashauri ya Temeke kwa kushirikiana    na Uongozi wa NACOPHA kupitia Mradi wa Sauti Yetu kwa kuweza kufanikisha    upatikanaji wa ofisi ya Konga ya Temeke.



Mkoa wa Dar es salaam ulipokea Mwenge wa Uhuru siku ya tarehe 25/05/2017 saa kutoka Mkoa wa Lindi katika eneo la Kongowe Shule ya Msingi Kongowe/Mzinga kata ya Tuangoma na kukabidhiwa katika wilaya ya Temeke. Mwenge wa Uhuru utamaliza mbio zake hapa mkoani Dar es salaam siku ya tarehe 31/05/2017 na kukabidhiwa kwa uongozi wa Mkoa wa Pwani siku ya tarehe 01/06/2017 katika uwanja wa ndege wa kimataifa wa Julius Nyerere Terminal 1 kwa ajiri ya kwenda Mafia Mkoani Pwani.

 
 


NACOPHA yakutana na Wabunge wa Bunge la Jamhuri ya Muungano wa Tanzania kujadili mwitikio wa UKIMWI nchini Tanzania.

Baraza la Taifa la Watu wanaoishi na Virusi vya UKIMWI Tanzania (NACOPHA) limekutana na Wabunge wa Bunge la Jamhuri ya Muungano wa Tanzania Mkoani Dodoma kujadili shughuli mbalimbali zinazofanywa na Baraza na Mwitikio wa UKIMWI nchini kwa sasa



Hapa ni Video ya Semina ya yaliyozungumzwa Bungeni na Baraza la Taifa la watu wanaoishi na VVU Tanzania Nacopha Tanzania katika Semina ya UKIMWI iliyofanyika Bungeni - Dodoma Tanzania kuhusu shughuli zinazoendeshwa na Baraza na hali ya mwitikio wa UKIMWI kwa sasa nchini Tanzania




Picha Mbalimbali za wawakilishi wa Baraza wakiwa Bungeni.




















Two years after I was diagnosed as being HIV positive, and declining to start ARV treatment after diagnoses, I contracted TB...

Today is World TB Day
The Theme is: Unite, Leave no one behind to End TB!




Today is World TB Day
The Theme is: Unite, Leave no one behind to End TB!
Two years after I was diagnosed as being HIV positive, and declining to start ARV treatment after diagnoses, I contracted TB... 

I was drastically loosing weight and getting weaker by the day...but never coughed at all.
My doctor was also puzzled as to what might be ailing me and he sent me to be admitted to hospital to be added blood and water.... but this did not help...
I was then discharged and asked to bring back my sputum, to which again nothing showed... 

I did an x- ray which only showed a dark area in my lungs indicating that I am a smoker...
Eventually a good friend of mine took me to another facility, so weak and unable to walk I had to be pulled into the facility in a wheelchair... with a measly weight of 35kg 
The doctor examined the very swollen lymph nodes on my neck and asked me why I sought treatment so late as I had active Tuberculosis...
He ordered a biopsy which proved that is was indeed the case...
I was immediately put on anti TB drugs which I had too take for eight months and within two months started ARV therapy...
My adherence to the TB medication makes me unlikely to contact TB again!
Tuberculosis (TB) is one of the top 10 causes of death worldwide. Common symptoms of active lung TB are cough with sputum and blood at times, chest pains, weakness, weight loss, fever and night sweats TB is a treatable and curable disease.
Do not ignore the symptoms associated with TB and do not stigmatize TB infected persons!
The pin I am wearing today shows a Red arrow leading towards Ending TB!


World Tuberculosis Day. "Unite to End TB: Leave no one behind"

World TB Day celebrated on 24 March each year, is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and care efforts. It is also an opportunity to mobilize political and social commitment for further progress in efforts to end TB.

The theme
Unite to End TB: Leave no one behind
2017 is the second year of a two-year "Unite to End TB" campaign for World TB Day. This year, WHO will place a special focus on uniting efforts to "Leave No One Behind", including actions to address stigma, discrimination, marginalization and overcome barriers to access care.
The Sustainable Development agenda embraces the principle of ensuring no one is left behind in an effort to transform the world and improve people’s lives for the better. Addressing the health needs of the disadvantaged, the marginalized, those out of reach of the health system will mean improving access to health services for everyone. This is essential in order to reach the target of ending TB by 2030 as part of the UN Sustainable Development Goals and the WHO End TB Strategy.
World TB Day provides the platform for affected persons and communities, civil society organizations, health-care providers, policy makers, development partners and others to advocate, discuss and plan further collaboration to fulfil the promise of reaching all people with quality TB prevention and care services, as well as enabling TB prevention through multisectoral development efforts.
Background
Last year, WHO reported that 10.4 million people fell ill with TB and there were 1.8 million TB deaths in 2015, making it the top infectious killer worldwide. This disease is deeply rooted in populations where human rights and dignity are limited. While anyone can contract TB, the disease thrives among people living in poverty, communities and groups that are marginalized, and other vulnerable populations.

These include: migrants, refugees, ethnic minorities, miners and others working and living in risk-prone settings, the elderly, marginalized women and children in many settings etc. Factors such as malnutrition, poor housing and sanitation, compounded by other risk factors such as tobacco and alcohol use and diabetes, affect vulnerability to TB and access to care. Furthermore, this access is often hindered by catastrophic costs associated with illness, seeking and staying in care, and lack of social protection, resulting in a vicious cycle of poverty and ill-health. The transmission of multidrug-resistant TB (MDR-TB) adds great urgency to these concerns.
Key facts
·         Tuberculosis (TB) is one of the top 10 causes of death worldwide.
·         In 2015, 10.4 million people fell ill with TB and 1.8 million died from the disease (including 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and middle-income countries.
·         Six countries account for 60% of the total, with India leading the count, followed by Indonesia, China, Nigeria, Pakistan and South Africa.
·         In 2015, an estimated 1 million children became ill with TB and 170 000 children died of TB (excluding children with HIV).
·         TB is a leading killer of HIV-positive people: in 2015, 35% of HIV deaths were due to TB.
·         Globally in 2015, an estimated 480 000 people developed multidrug-resistant TB (MDR-TB).
·         TB incidence has fallen by an average of 1.5% per year since 2000. This needs to accelerate to a 4–5% annual decline to reach the 2020 milestones of the "End TB Strategy".
·         An estimated 49 million lives were saved through TB diagnosis and treatment between 2000 and 2015.
·         Ending the TB epidemic by 2030 is among the health targets of the newly adopted Sustainable Development Goals.



Tuberculosis (TB) is caused by bacteria (Mycobacterium tuberculosis) that most often affect the lungs. Tuberculosis is curable and preventable.

TB is spread from person to person through the air. When people with lung TB cough, sneeze or spit, they propel the TB germs into the air. A person needs to inhale only a few of these germs to become infected.

About one-third of the world's population has latent TB, which means people have been infected by TB bacteria but are not (yet) ill with the disease and cannot transmit the disease.

People infected with TB bacteria have a 10% lifetime risk of falling ill with TB. However, persons with compromised immune systems, such as people living with HIV, malnutrition or diabetes, or people who use tobacco, have a much higher risk of falling ill.
When a person develops active TB disease, the symptoms (such as cough, fever, night sweats, or weight loss) may be mild for many months. This can lead to delays in seeking care, and results in transmission of the bacteria to others. People with active TB can infect 10–15 other people through close contact over the course of a year. Without proper treatment, 45% of HIV-negative people with TB on average and nearly all HIV-positive people with TB will die.
Who is most at risk?
Tuberculosis mostly affects adults in their most productive years. However, all age groups are at risk. Over 95% of cases and deaths are in developing countries.
People who are infected with HIV are 20 to 30 times more likely to develop active TB (see TB and HIV section below). The risk of active TB is also greater in persons suffering from other conditions that impair the immune system.

One million children (0–14 years of age) fell ill with TB, and 170 000 children (excluding children with HIV) died from the disease in 2015.
Tobacco use greatly increases the risk of TB disease and death. More than 20% of TB cases worldwide are attributable to smoking.
Global impact of TB
TB occurs in every part of the world. In 2015, the largest number of new TB cases occurred in Asia, with 61% of new cases, followed by Africa, with 26% of new cases.
In 2015, 87% of new TB cases occurred in the 30 high TB burden countries. Six countries accounted for 60% of the new TB cases: India, Indonesia, China, Nigeria, Pakistan, and South Africa. Global progress depends on advances in TB prevention and care in these countries.
Symptoms and diagnosis
Common symptoms of active lung TB are cough with sputum and blood at times, chest pains, weakness, weight loss, fever and night sweats. Many countries still rely on a long-used method called sputum smear microscopy to diagnose TB. Trained laboratory technicians look at sputum samples under a microscope to see if TB bacteria are present. Microscopy detects only half the number of TB cases and cannot detect drug-resistance.

The use of the rapid test Xpert MTB/RIF® has expanded substantially since 2010, when WHO first recommended its use. The test simultaneously detects TB and resistance to rifampicin, the most important TB medicine. Diagnosis can be made within 2 hours and the test is now recommended by WHO as the initial diagnostic test in all persons with signs and symptoms of TB. More than 100 countries are already using the test and 6.2 million cartridges were procured globally in 2015.
Diagnosing multi-drug resistant and extensively drug-resistant TB (see Multidrug-resistant TB section below) as well as HIV-associated TB can be complex and expensive. In 2016, 4 new diagnostic tests were recommended by WHO – a rapid molecular test to detect TB at peripheral health centres where Xpert MTB/RIF cannot be used, and 3 tests to detect resistance to first- and second-line TB medicines.
Tuberculosis is particularly difficult to diagnose in children and as yet only the Xpert MTB/RIF assay is generally available to assist with the diagnosis of paediatric TB.
Treatment
TB is a treatable and curable disease. Active, drug-susceptible TB disease is treated with a standard 6 month course of 4 antimicrobial drugs that are provided with information, supervision and support to the patient by a health worker or trained volunteer. Without such support, treatment adherence can be difficult and the disease can spread. The vast majority of TB cases can be cured when medicines are provided and taken properly.
Between 2000 and 2015, an estimated 49 million lives were saved through TB diagnosis and treatment.
TB and HIV
At least one-third of people living with HIV worldwide in 2015 were infected with TB bacteria. People living with HIV are 20 to 30 times more likely to develop active TB disease than people without HIV.
HIV and TB form a lethal combination, each speeding the other's progress. In 2015 about 0.4 million people died of HIV-associated TB. About 35% of deaths among HIV-positive people were due to TB in 2015. In 2015 there were an estimated 1.2 million new cases of TB amongst people who were HIV-positive, 71% of whom were living in Africa.
WHO recommends a 12-component approach of collaborative TB-HIV activities, including actions for prevention and treatment of infection and disease, to reduce deaths.
Multidrug-resistant TB
Anti-TB medicines have been used for decades and strains that are resistant to 1 or more of the medicines have been documented in every country surveyed. Drug resistance emerges when anti-TB medicines are used inappropriately, through incorrect prescription by health care providers, poor quality drugs, and patients stopping treatment prematurely.
Multidrug-resistant tuberculosis (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most powerful, first-line anti-TB drugs. MDR-TB is treatable and curable by using second-line drugs. However, second-line treatment options are limited and require extensive chemotherapy (up to 2 years of treatment) with medicines that are expensive and toxic.
In some cases, more severe drug resistance can develop. Extensively drug-resistant TB (XDR-TB) is a more serious form of MDR-TB caused by bacteria that do not respond to the most effective second-line anti-TB drugs, often leaving patients without any further treatment options.
About 480 000 people worldwide developed MDR-TB in 2015. In addition, around 100 000 people developed resistance to rifampicin (the most effective first-line medicine) and needed MDR-TB treatment. The MDR-TB burden largely falls on 3 countries – China, India, and the Russian Federation – which together account for nearly half of the global cases. About 9.5% of MDR-TB cases had XDR-TB in 2015.
Worldwide, only 52% of MDR-TB patients and 28% of XDR-TB are currently successfully treated. In 2016, WHO approved the use of a short, standardised regimen for MDR-TB patients who do not have strains that are resistant to second-line TB medicines. This regimen takes 9–12 months and is much less expensive than the conventional treatment for MDR-TB, which can take up to 2 years. Patients with XDR-TB or resistance to second-line anti-TB drugs cannot use this regimen, however, and need to be put on longer MDR-TB regimens to which 1 of the new drugs (bedquiline and delamanid) may be added.
WHO also approved in 2016 a rapid diagnostic test to quickly identify these patients. More than 20 countries in Africa and Asia have started using shorter MDR-TB regimens. By the end of 2015, 70 countries had introduced bedaquiline and 39 countries had introduced delamanid, in an effort to improve the effectiveness of MDR-TB treatment regimens.
WHO response
WHO pursues 6 core functions in addressing TB:
1.     Providing global leadership on matters critical to TB.
2.    Developing evidence-based policies, strategies and standards for TB prevention, care and control, and monitoring their implementation.
3.    Providing technical support to Member States, catalyzing change, and building sustainable capacity.
4.    Monitoring the global TB situation, and measuring progress in TB care, control, and financing.
5.    Shaping the TB research agenda and stimulating the production, translation and dissemination of valuable knowledge.
6.    Facilitating and engaging in partnerships for TB action.
The WHO "End TB Strategy", adopted by the World Health Assembly in May 2014, is a blueprint for countries to end the TB epidemic by driving down TB deaths, incidence and eliminating catastrophic costs. It outlines global impact targets to reduce TB deaths by 90%, to cut new cases by 80% between 2015 and 2030, and to ensure that no family is burdened with catastrophic costs due to TB.
Ending the TB epidemic by 2030 is among the health targets of the newly adopted Sustainable Development Goals. WHO has gone one step further and set a 2035 target of 95% reduction in deaths and a 90% decline in TB incidence – similar to current levels in low TB incidence countries today.

The Strategy outlines three strategic pillars that need to be put in place to effectively end the epidemic:
·         Pillar 1: integrated patient-centred care and prevention
·         Pillar 2: bold policies and supportive systems
·         Pillar 3: intensified research and innovation
The success of the Strategy will depend on countries respecting the following 4 key principles as they implement the interventions outlined in each pillar:
·         government stewardship and accountability, with monitoring and evaluation
·         strong coalition with civil society organizations and communities
·         protection and promotion of human rights, ethics and equity
·         adaptation of the strategy and targets at country level, with global collaboration.

NACOPHA TUNAUNGANA NA WANAWAKE WOTE TANZANIA KATIKA KUADHIMISHA SIKU YA MWANAMKE DUNIANI KWA KUSEMA HAIJALISHI HALI YA MAAMBUKIZO YA VVU “TANZANIA YA VIWANDA: WANAWAKE NI MSINGI WA MABADILIKO YA KIUCHUMI”


·         Tujikumbushe
·         Historia ya Siku ya Wanawake:

·        
Siku ya Wanawake ilianza mwanzoni mwa miaka ya 1900 kwa kupitia wanawake wafanyakazi wa sekta ya viwanda nchini Marekani walioandamana kupinga mazingira duni ya kazi zao, walilalamikia ukosefu wa huduma za kijamii na kuwepo kwa vitendo vya unyanyasaji katika ajira. Kutokana na hali hiyo, nchi ya Marekani ilikubali kuwa na siku ya maadhimisho ya kitaifa ili kutafakari masuala mbalimbali yanayohusu haki na ustawi wa wanawake.

·         Baadaye Umoja wa Mataifa ulipaoanzishwa mwaka 1945, ilipofika tarehe 8 Machi iliridhiwa iwe Siku ya Kimataifa ya Wanawake Duniani. Uamuzi huo wa Umoja wa Mataifa ulitokana na kukubali kwake kwamba masuala ya haki, maendeleo na usawa wa wanawake yalihitaji msukumo maalumu na wa pekee.
·         Madhumuni ya kuadhimisho ya Siku ya Wanawake Duniani ni kuwezesha jamii kupima utekelezaji wa maazimio, matamko, mikataba na itifaki mbalimbali za Kimataifa/ kikanda na kitaifa zinazohusu masuala ya maendeleo ya jinsia na wanawake katika kuhakikisha haki za wanawake kiuchumi, kijamii, na kisiasa zinapatikana na zinalidwa.
·          
·         Aidha, kuadhimisha Siku ya Wanawake Duniani ni kuhamasisha jamii kuhusu umuhimu wa kutambua na kuthamini uwezo na mchango mkubwa wa wanawake katika kuleta maendeleo, kuelezea jitihada mbalimbali zilizofanywa na Serikali na wadau wengine katika kuwajengea uwezo wa kiuchumi na kijamii ili waweze kushiriki kikamilifu kujiletea maendeleo yao, familia zao na Taifa kwa ujumla.
·         Tanzania ilianza kuadhimisha Siku ya Wanawake Duniani mwaka 1996, maadhimisho yamekuwa yakiandaliwa Kitaifa na katika ngazi ya mkoa.

     Hivyo maadhimisho ya mwaka huu 2017 yanasisitiza Kaulimbiu ya kitaifa ambayo ni; “TANZANIA YA VIWANDA: WANAWAKE NI MSINGI WA MABADILIKO YA KIUCHUMI”.